Website stats for Alkeuspharma - alkeuspharma.com
» About Us Our team is experienced and dedicated to developing treatments for blindness. We collaborate heavily with leading physicians worldwide. Click here to learn more about Alkeus Pharmaceuticals.
alkeuspharma.com was registered 1 decade 4 years ago. It has a alexa rank of #6,190,802 in the world. It is a domain having .com extension. It is estimated worth of $ 240.00 and have a daily income of around $ 1.00. As no active threats were reported recently, alkeuspharma.com is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 142 |
| Daily Pageviews: | 284 |
Estimated Valuation
| Income Per Day: | $ 1.00 |
| Estimated Worth: | $ 240.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 6,190,802 |
| PageSpeed Score: | 92 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
34.197.89.244
Hosted Country:
US
Location Latitude:
39.0437Location Longitude:
-77.4875Traffic Classification
| Total Traffic: | No Data |
| Direct Traffic: | No Data |
| Referral Traffic: | No Data |
| Search Traffic: | No Data |
| Social Traffic: | No Data |
| Mail Traffic: | No Data |
| Display Traffic: | No Data |
Search Engine Results For alkeuspharma.com
Alkeus Pharma
Alkeus Pharma is a clinical stage biopharmaceutical company » dry-AMD The most common form of unpreventable blindness, dry-AMD affects the vision of millions of Americans.
Alkeus Pharmaceuticals - Home | Facebook
Alkeus Pharmaceuticals, Boston, Massachusetts. 212 likes. Alkeus develops treatment for serious untreatable causes of blindness, in particular Stargardt disease and dry...
Alkeus Pharmaceuticals Company Profile: Valuation ...
Oct 21, 2010 · Alkeus Pharmaceuticals General Information Description. Developer of treatments for blindness. The company develops a new oral investigational medicine, …
alkeuspharma.com (Alkeus Pharmaceuticals: Developing ...
alkeuspharma.com (hosted on amazon.com) details, including IP, backlinks, redirect information, and reverse IP shared hosting data
Alzheon | Preserving Future Memories
Alzheon is committed to developing breakthrough medicines for patients suffering from Alzheimer's disease and other neurological disorders.
Home | Allena
Read more about Allena Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update
Alkeus Pharmaceuticals - Overview, News & Competitors ...
Alkeus Pharmaceuticals’s headquarters are in 278 Elm St, Ste 229, Somerville, Massachusetts, 02144, United States What is Alkeus Pharmaceuticals’s official website? Alkeus...
Alkeus Pharmaceuticals, Boston, MA (2020)
Stargardt disease is a genetic disease that causes improper transport of vitamin A in the eye and in the formation of toxic vitamin A aggregates responsible for vision loss.
Alkeus Pharmaceuticals, Inc. in Boston, MA | Company Info ...
Alkeus Pharmaceuticals, Inc. is a Massachusetts Foreign Corporation filed on December 19, 2011. The company's File Number is listed as 001067348. The Registered Agent on file...
Alkeus Pharmaceuticals, Inc. | LinkedIn
Alkeus Pharmaceuticals, Inc. | 169 followers on LinkedIn. Developing a new treatment for dry age-related macular degeneration and Stargardt disease.
Alkeus Pharmaceuticals DMF, CEP, Written Confirmations ...
Alkeus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering and developing treatments against serious and untreatable diseases of the eye. The...
Stargardt's Disease - Causes, Symptoms & Experimental ...
Alkeus Pharmaceuticals licenses novel compounds from Columbia University for potential treatments of ophthalmologic conditions such as dry-AMD and Stargardt disease. Alkeus...
A primer of deuterium in drug design | Future Medicinal ...
Sep 20, 2019 · Concluding remarks. D substitution is the smallest possible structural change that can be made to a molecule and it follows that its incorporation appears to be...
Home | Allysta
Allysta Pharmaceuticals is a private venture-backed clinical stage biopharmaceutical company. We are developing first-in-class therapeutic peptides that uniquely target...
Contact | Allena
Headquarters. Allena Pharmaceuticals One Newton Executive Park Suite 202 Newton, MA 02462 Email: [email protected] Phone: 617-467-4577 Fax: 617-916-1871
Agenus - The Right Combination
Agenus discovers, manufactures and develops immuno-oncology products. The company’s I-O portfolio is comprised of checkpoint antibodies, cell therapies, vaccines, and adjuvants,...
Product registration - A.O. Smith
Necessary Cookies. These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by...
TEASE Stargardt Disease Clinical Studies – Study of ALK ...
Introducing the TEASE Studies Stargardt disease, also known as "Stargardt macular degeneration", is an inherited eye condition that leads to loss of central vision during...
Phase 3 Study of ALK-001 in Geographic Atrophy - Full Text ...
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S....
Alkeus Pharmaceuticals – 2012 Fierce 15 | FierceBiotech
Sep 19, 2012 · Leonide Saad, CEO of Alkeus Pharmaceuticals Based: Boston Founded: March 2010 CEO: Leonide Saad Focus: Treatments for blindness Website: www.alkeus.com The Scoop:...
Global Geographic Atrophy Market Outlook 2020-2030 ...
DUBLIN, Aug. 24, 2020 /PRNewswire/ -- The "Geographic Atrophy - Market Insights, Epidemiology and Market Forecast - 2030" drug pipelines has been added to...
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | 1 | H2 Headings: | 5 |
| H3 Headings: | Not Applicable | H4 Headings: | Not Applicable |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | Not Applicable | Total Images: | 1 |
| Google Adsense: | Not Applicable | Google Analytics: | UA-15584027-1 |
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Connection: close
Content-Type: text/html
Last-Modified: Tue, 27 Jun 2017 23:44:51 GMT
Etag: "10c4-5952edf3-7f68ce8959a969fc;gz"
Accept-Ranges: bytes
Content-Encoding: gzip
Vary: Accept-Encoding
Content-Length: 1711
Date: Mon, 23 Sep 2019 03:43:10 GMT
Server: LiteSpeed
Domain Information
| Domain Registrar: |
GoDaddy.com, LLC
|
|---|---|
| Registration Date: | 2010-02-18 1 decade 4 years 9 months ago |
| Last Modified: | 2018-01-18 6 years 10 months 5 days ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| ns1.hostica.com | |
13.248.158.180 | United States |
| ns2.hostica.com | |
75.2.118.134 | United States |
| ns3.hostica.com | |
76.223.26.245 | United States |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| alkeuspharma.com | A | 86313 |
IP: 34.197.89.244 |
| alkeuspharma.com | NS | 86400 |
Target: ns3.hostica.com |
| alkeuspharma.com | NS | 86400 |
Target: ns1.hostica.com |
| alkeuspharma.com | NS | 86400 |
Target: ns2.hostica.com |
| alkeuspharma.com | SOA | 86400 |
MNAME: ns1.hostica.com RNAME: hostmaster.plainhost.com Serial: 2017022104 Refresh: 10800 Retry: 3600 Expire: 604800 |
| alkeuspharma.com | MX | 86400 |
Priority: 500 Target: mail10.hostica.com |
Full WHOIS Lookup
Registry Domain ID:
1585778112_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.godaddy.com
Registrar URL:
http://www.godaddy.com
Updated Date:
2018-01-18T14:37:19Z
Creation Date:
2010-02-17T22:34:35Z
Registry Expiry Date:
2020-02-17T22:34:35Z
Registrar: GoDaddy.com, LLC
Registrar
IANA ID: 146
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
480-624-2505
Domain Status: clientDeleteProhibited
https://icann.org/epp#clientDeleteProhibited
Domain Status:
clientRenewProhibited
https://icann.org/epp#clientRenewProhibited
Domain Status:
clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Domain Status:
clientUpdateProhibited
https://icann.org/epp#clientUpdateProhibited
Name Server:
NS1.HOSTICA.COM
Name Server: NS2.HOSTICA.COM
Name Server:
NS3.HOSTICA.COM
DNSSEC: unsigned
URL of the ICANN Whois
Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last
update of whois database: 2019-09-23T03:43:44Z
Similarly Ranked Websites
New Kia and Used Car Dealer Serving Ramsey | Liberty Kia
Visit Liberty Kia for a variety of new and used cars by Kia, serving Ramsey, New Jersey. We serve Spring Valley NY, Chestnut Ridge NY, Fair Lawn and Mahwah and are ready to...
6,190,900 
$ 240.00
Mudleaf Coffee
Mudleaf Coffee is here to bring delicious, hand-crafted coffee to your special event in North Texas. Our first location is now open in Plano!
6,190,929 $ 240.00